Meeting
2017 Gastrointestinal Cancers Symposium
Tumor mutational burden of microsatellite stable metastatic colorectal tumors by patient factors and KRAS, BRAF, and PIK3CA mutation status.
Authors
Jun Gong
City of Hope National Medical Center, Duarte, CA
Jun Gong , Marvin Sy , Marwan Fakih
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 627)
DOI
10.1200/JCO.2017.35.4_suppl.627
Abstract #
627
Poster Bd #
F1
Abstract Disclosures
Similar Posters
First Author: Sandra Algaze
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC).
First Author: Anwaar Saeed
Poster
2019 ASCO Annual Meeting
Randomized phase II study on the influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab (Bev) or cetuximab (Cet), as first line therapy of patients (pts) with RAS wild-type metastatic colorectal carcinoma (mCRC) and <3 baseline circulating tumor cells (bCTCs).
First Author: Enrique Aranda
Poster
2019 Gastrointestinal Cancers Symposium
Molecular comparison of primary colorectal cancer (pCRC) with peritoneal metastases (PM).
First Author: Matthew K Stein